Open links in new tab
  1. Copilot Answer

    Orphan Drug Designation

    Organizing and summarizing search results for you
    Orphan drug designation:
    • Refers to a status designated by the FDA.
    • Gives companies researching cures for rare diseases a seven-year window of exclusive marketing rights post-approval.
    • Provides reductions in certain application fees and tax incentives.
    • Is granted if the drug is being investigated for a rare disease or condition.
    • The drug must treat a condition affecting fewer than 200,000 persons in the United States or not be profitable within 7 years following FDA approval.